Founded 2022
Founders Dr. Emilia McLaughlin, CTO, kyron.bio

We have made giant leaps in drug discovery over the past 10 years. However, the bioproduction industry cannot keep up. Complex proteins are challenging to produce at high yields and in a reliable fashion, and in order to reap the rewards of recent advances in drug discovery a bioproduction revolution is needed.

kyron.bio is building the bioproduction platform of the future by harnessing highly efficient processes from diverse organisms and genetically engineering them into existing bioproduction platforms. Our patentable technology boosts both the effectiveness and yield of therapeutic proteins produced in mammalian cell factories. We are guided by leaders from GSK, Sanofi and Bayer.

kyron.bio’s mission is to help bring better, cheaper and novel biopharmaceuticals to market.


Founders

Dr. Emilia
McLaughlin

CTO, kyron.bio

PhD in cell and molecular biology, 6+ years experience studying evolutionarily diverse life forms

Linkedin

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.